SCHEMBL6318548

SCHEMBL6318548

O=C(NCc1cc(C(=O)O)c(NC(=O)C(=O)O)s1)Oc1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.41
PTPN2 P17706 1/20 0.39
PTPRB P23467 1/20 0.39
PTPN6 P29350 1/20 0.39
MAPT P10636 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
PTPN1 P18031 1/20 0.38
ALDH1A1 P00352 4/20 0.36
CYP1A2 P05177 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
GRIN2C Q14957 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HTT P42858 2/20 0.34
PPARA Q07869 1/20 0.34
PTGER4 P35408 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318762 0.90 HSD17B10 (0.45) PTPN2PTPRBPTPN6MAPTNPC1
SCHEMBL6313183 0.89 MGLL (0.42) PTPN2PTPRBPTPN6MAPTNPC1
SCHEMBL6318638 0.89 MAPT (0.50) PTPN2PTPRBPTPN6MAPTNPC1
SCHEMBL6312273 0.85 MGLL (0.46) FAAHPTPN2PTPRBPTPN6MAPT
SCHEMBL6318495 0.81 ALDH1A1 (0.44) PTPN2PTPRBPTPN6MAPTNPC1
SCHEMBL6316825 0.78 HSD17B10 (0.48) PTPN2PTPRBPTPN6MAPTNPC1
SCHEMBL6311428 0.77 PTPN2 (0.38) PTPN2PTPRBPTPN6MAPTNPC1
SCHEMBL6310728 0.77 MAPT (0.43) PTPN2PTPRBPTPN6MAPTNPC1
SCHEMBL6312575 0.77 ALDH1A1 (0.41) PTPN2PTPRBPTPN6MAPTNPC1
SCHEMBL6317838 0.76 CYP19A1 (0.43) PTPN1ALDH1A1CYP1A2KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020165398-A1 Modulators of protein tyrosine phosphatases (PTPases) JEPPESEN LONE (DK) 2002-11-07 US claimed
US-20020002199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-03 US claimed
EP-1062204-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2000-12-27 EP claimed
WO-1999046244-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO claimed
US-20050119332-A1 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) JEPPESEN LONE (DK) 2005-06-02 US disclosed
US-20020165398-A1 Modulators of protein tyrosine phosphatases (PTPases) JEPPESEN LONE (DK) 2002-11-07 US disclosed
US-20020002199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-03 US disclosed
EP-1062204-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2000-12-27 EP disclosed
WO-1999046244-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020165398-A1 Modulators of protein tyrosine phosphatases (PTPases) PTPRCAP, PTPRS, PTPRO FAAH 1555/4885PTPN2 8/4885PTPRB 25/4885
US-20020002199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) PTPRCAP, PTPRS, PTPRA FAAH 1527/4885PTPN2 9/4885PTPRB 25/4885
US-20050119332-A1 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) PTPRCAP, PTPRS, PTPN1 FAAH 1617/4885PTPN2 11/4885PTPRB 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.